ECigIntelligence || 23rd March 2022 || News analysis || FDA | Nicotine | Regulation and Legislation | Geographies: North America United States
The passage of the $1.5tn
and its rider giving the US Food and Drug Administration (FDA) authority to regulate synthetic nicotine products in the same way that tobacco products are regulated will omnibus spending bill irrevocably change the US vaping market.
Now that president Joe Biden has signed the bill into law, there are a number of major milestones to look out for over the coming months. ECigIntelligence has put together a timeline outlining the major points to look out for over the summer as the FDA brings synthetic nicotine into the PMTA process.
– ECigIntelligence staff
Enjoy free subscription access Get access to premium content that is normally only available for subscribers. For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors. Benefits of subscription plans: Stay informed of any legal and market change in the sector that impacts your organization Maximise resources by getting market and legal data analysis daily in one place Make smart decisions by understanding how the regulatory and market landscape evolves Anticipate risks in your decisions by monitoring regulatory changes that impact your organization